Source: Annual Congress 2009 - Environmental factors, susceptibility, asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Henneberger, M. Mirabelli, M. Kogevinas, J. Antó, E. Plana, A. Dahlman-Höglund, D. Jarvis, H. Kromhout, L. Lillienberg, D. Norbäck, M. Olivieri, K. Radon, K. Torén, I. Urrutia, S. Villani, J. P. Zock (Morgantown, United States Of America; Barcelona, Galdakao, Spain; Göteborg, Uppsala, Sweden; London, United Kingdom; Utrecht, Netherlands; Verona, Pavia, Italy; Munich, Germany). The occupational contribution to severe exacerbation of current asthma. Eur Respir J 2009; 34: Suppl. 53, 4421

Member's Comments

No comment yet.

Related content which might interest you: The occupational contribution to severe exacerbation of asthma Source: Eur Respir J 2010; 36: 743-750 Year: 2010 The frequency of workplace exacerbation of asthma Source: Eur Respir J 2005; 26: Suppl. 49, 34s Year: 2005 Work-related asthma and occupational asthma: clinical approach Source: Annual Congress 2005 - Occupational asthma Year: 2005 Reduction of work exposure is not associated with improvement in functional and biological findings in occupational asthma Source: Annual Congress 2006 - Asthma at the workplace – the prognosis and the costs Year: 2006 Eosinophilic inflammation decreases in subjects with occupational asthma despite persistence of occupational exposure Source: Eur Respir J 2002; 20: Suppl. 38, 130s Year: 2002 Sensitiser-induced occupational asthma Source: Eur Respir Monogr 2020; 89: 34-51 Year: 2020 The impact of occupational and other environmental exposures on the aetiology of COPD, bronchitis and bronchiolitis Source: Eur Respir Monogr 2020; 89: 86-103 Year: 2020 Prediction of the risk of future exacerbations in patients with severe persistent allergic asthma Source: Annual Congress 2005 - Severe asthma: perception and management Year: 2005 The ERS/EAACI statement on severe exacerbations of asthma, and how to deal with non-allergic severe asthma Source: International Congress 2019 – Pathophysiology and clinical insights into severe non-allergic asthma Year: 2019 Distribution of biomarkers in severe asthma and severe uncontrolled asthma Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research Year: 2021 Occupational exposures and asthma–COPD overlap in a clinical cohort of adult-onset asthma Source: ERJ Open Res, 5 (4) 00191-2019; 10.1183/23120541.00191-2019 Year: 2019 Dupilumab improves lung function and reduces severe exacerbations in uncontrolled persistent asthma patients with ongoing allergic rhinitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Relationship between benralizumab exposure and asthma exacerbation rate for patients with severe asthma Source: International Congress 2017 – Asthma: mechanisms and treatment Year: 2017 Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma Source: Eur Respir J 2002; 19: 846-852 Year: 2002 Omalizumab treatment reduces asthma exacerbations in children with moderate or severe persistent asthma Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues Year: 2017 Difficult-to-treat asthma: how serious is the problem and what are the issues? Source: Eur Respir Mon 2011; 51: 1-15 Year: 2011 Occupational asthma: the causes and resolution of an outbreak Source: Annual Congress 2007 - Occupation and obstruction Year: 2007 Does previous exposure to occupational dust or gas give increased incidence of respiratory symptoms and asthma? Source: Eur Respir J 2001; 18: Suppl. 33, 200s Year: 2001 Continuous objective assessment of wheezing in adult asthma patients hospitalised following an acute exacerbation of asthma Source: Eur Respir J 2001; 18: Suppl. 33, 267s Year: 2001